Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections

Shionogi

Status

Conditions: Bacterial Infections

Treatments: Drug: Cefiderocol

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT03780140

S-649266-EA

Details and patient eligibility

About

Expanded access may be provided for cefiderocol for qualified patients who have limited treatment options and are not eligible for a clinical trial.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Hospitalized patients with serious Gram-negative bacterial infections and who have limited treatment options and are not eligible for a clinical trial.